Healthcare

As the Healthcare sector emerges from a time of immense pressure and high visibility, we see huge investment, potential and opportunity ahead

Truly dynamic and innovative at its core, Healthcare is poised for a period of growth and transformation. Driven by a range of factors – including Covid-19; greater emphasis on personalisation; digitisation and technological innovation; changing demographics; and shifting customer and patient expectations – organisations of all sizes and ownership structures seek the right leaders to seize this opportunity.

Supporting clients at Board, Executive Committee and leadership levels, we combine extensive experience in and a deep understanding of the wide and varied Healthcare sector, including its clinical leadership, as well as access to relevant talent pools in adjacent consumer-facing industries.

View current opportunities

The MBS Group acts as an advisor to NHS and other public sector bodies on senior appointments. To view current appointments, click here.

Our Experience

Clinical Services

Life Sciences
HealthTech & Digital Healthcare
Insurers
Healthcare Systems
Medical Devices & Diagnostics

Selected Clients

Latest MBS News & Intelligence

Exemplar Health Care completes 33 bed care home in Staffordshire amid new staffing boost. UK complex care provider Exemplar Health Care has completed a 33-bed home in Cannock for adults with brain injuries, dementia and other needs. The site will create around 100 jobs over the year to 19 June 2025.
Bupa to buy new hospital. Bupa is set to buy New Victoria Hospital, an independent private hospital in Kingston upon Thames. This is its first UK hospital acquisition since 2008.
Sword Health raises $40m at $4bn valuation and pushes IPO to 2028. Sword Health has secured $40m at a $4bn valuation, up from $3bn last year. The AI health platform, now cash-flow positive, is delaying IPO plans to 2028 as it expands beyond virtual physio into new care areas. Investors include General Catalyst and Khosla.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.